Montero VD, Pacheco MM, Abarca BI

Idioma: Español
Referencias bibliográficas: 15
Paginas:
Archivo PDF: 127.71 Kb.

RESUMEN

La vancomicina es un antimicrobiano de uso frecuente a nivel intrahospitalario para el tratamiento de infecciones graves por Staphylococcus aureus meticilino resistente. Entre sus efectos secundarios de mayor cuidado se encuentra la nefrotoxicidad. Esta, en presencia de otros factores de riesgo propios del paciente, predispone la aparición de la lesión renal aguda.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mercado MG, Smith DK, Guard EL. Acute kidney injury: Diagnosis and management. Am Fam Physician [Internet]. 2019 [cited Mar 18, 2022];100(11):687–94. Available from: https://pubmed.ncbi.nlm.nih.gov/31790176/

2. Levey AS, James MT. Acute kidney injury. Ann Intern Med [Internet]. 2017;167(9):ITC66. Doi: http://dx.doi.org/10.7326/aitc201711070

3. Jacob J, Dannenhoffer J, Rutter A. Acute kidney injury. Prim Care [Internet]. 2020;47(4):571–84. Doi: http://dx.doi.org/10.1016/j.pop.2020.08.008

4. Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primers [Internet]. 2021 [cited Mar 20, 2022];7(1):52. Available from: https://pubmed.ncbi.nlm.nih.gov/34267223/

5. Küllmar M, Zarbock A, Engelman DT, Chatterjee S, Wagner N-M. Prevention of acute kidney injury. Crit Care Clin [Internet]. 2020;36(4):691–704. Doi: http://dx.doi.org/10.1016/j.ccc.2020.07.002

6. Ebstein N, Gaudry S, Cohen Y. Tratamiento de la lesión renal aguda en cuidados intensivos (excluyendo la depuración renal). EMC - Anest-Reanim [Internet]. 2021;47(4):1–14. Doi: http://dx.doi.org/10.1016/s1280-4703(21)45674-4

7. Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab [Internet]. 2016 [cited Mar 20, 2022];7(3):136–47. Available from: https://pubmed.ncbi.nlm.nih.gov/27293542/

8. Filippone EJ, Kraft WK, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther [Internet]. 2017;102(3):459–69. Doi: http://dx.doi.org/10.1002/cpt.726

9. Tantranont N, Hebert S, Truong LD. Vancomycin nephrotoxicity causing renal transplant acute kidney injury. Transplant Proc [Internet]. 2021;53(10):2913–7. Doi: http://dx.doi.org/10.1016/j.transproceed.2021.09.033

10. Soares D, Reis A, da Silva G, Tavares T, Parente Filho SLA, de Oliveira C, et al. Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients. Pathog Glob Health [Internet]. 2017;111(3):137–42. Doi: http://dx.doi.org/10.1080/20477724.2017.1309338

11. Pais GM, Liu J, Zepcan S, Avedissian SN, Rhodes NJ, Downes KJ, et al. Vancomycin-induced kidney injury: Animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention. Pharmacotherapy [Internet]. 2020;40(5):438–54. Doi: http://dx.doi.org/10.1002/phar.2388

12. Wang Y, Dai N, Wei W, Jiang C. Outcomes and nephrotoxicity associated with vancomycin treatment in patients 80 years and older. Clin Interv Aging [Internet]. 2021;16:1023–35. Doi: http://dx.doi.org/10.2147/CIA.S308878

13. Jeffres MN. The whole price of vancomycin: Toxicities, troughs, and time. Drugs [Internet]. 2017;77(11):1143–54. Doi: http://dx.doi.org/10.1007/s40265-017-0764-7

14. Blair M, Côté J-M, Cotter A, Lynch B, Redahan L, Murray PT. Nephrotoxicity from vancomycin combined with piperacillin-tazobactam: A comprehensive review. Am J Nephrol [Internet]. 2021;52(2):85–97. Doi: http://dx.doi.org/10.1159/000513742

15. Fiorito TM, Luther MK, Dennehy PH, LaPlante KL, Matson KL. Nephrotoxicity with vancomycin in the pediatric population: A systematic review and meta-analysis. Pediatr Infect Dis J [Internet]. 2018;37(7):654–61. Doi: http://dx.doi.org/10.1097/inf.0000000000001882